Clinical Trial Update: Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clarithromycin plus a CTd regimen in newly diagnosed multiple myeloma; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN